Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Popular weight loss drugs like Ozempic might be able to help with substance abuse, according to new research on people ...
A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...
Obesity Health Alliance writes to Health Secretary Wes Streeting after he announced a massive expansion of ...
Zmyra is known as the top over-the-counter alternative to Wegovy for weight loss. This natural supplement packs a punch with ...
Wes Streeting responded to a Sky News report which found the NHS rollout of the "game-changing" weightloss drug has been slower than planned by saying it could risk fuelling a rise in eating disorders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback